[EN] ARYLMETHYLENE AROMATIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS<br/>[FR] COMPOSÉS AROMATIQUES D'ARYLMÉTHYLÈNE EN TANT QUE BLOQUEURS DES CANAUX D'AGITATEUR POTASSIQUE KV1.3
申请人:DE SHAW RES LLC
公开号:WO2021071821A1
公开(公告)日:2021-04-15
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.
描述一种化合物 Formula (I) 或其药用可接受的盐,其中取代基如本文所定义。还描述了包含该化合物的药物组合物以及使用该化合物的方法。
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
申请人:Carson Rebekah J.
公开号:US20100305115A1
公开(公告)日:2010-12-02
The present invention relates to compounds of formula (I) wherein c, X, Y, R
2
, R
3
, R
4
and R
6
are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection
[EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2009062288A1
公开(公告)日:2009-05-22
The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection